GO:0010965 regulation of mitotic sister chromatid separation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010965 describes any process that modulates the frequency, rate or extent of mitotic sister chromatid separation, the physical detachment of sister chromatids during mitosis.
• The spindle assembly checkpoint (SAC) is a major regulator that delays anaphase until all chromosomes are correctly attached to the mitotic spindle.
• Separase (Cut1/separin) and securin (Cut2) are central effectors; securin inhibits separase until its ubiquitin-mediated degradation triggers sister chromatid separation.
• Ubiquitination and deubiquitination of PLK1 control the equilibrium that regulates sister chromatid separation.
• Anaphase B, driven by spindle elongation, is a key mechanical phase of sister chromatid separation and is regulated by multiple factors.
• Deregulation of sister chromatid separation contributes to aneuploidy and cancer, making its components attractive research and therapeutic targets.
Description
Regulation of mitotic sister chromatid separation (GO:0010965) is a biological process that modulates the frequency, rate or extent of the physical detachment of sister chromatids during mitosis. Accurate sister chromatid separation is essential for faithful chromosome segregation, and its deregulation leads to aneuploidy, a hallmark of cancer and developmental disorders. The process is tightly controlled by the spindle assembly checkpoint (SAC), which monitors kinetochore-microtubule attachments and delays anaphase until all chromosomes are properly bi-oriented. Key molecular players include separase, a protease that cleaves cohesin, and securin, its inhibitory chaperone; the ubiquitin-proteasome system times securin degradation to trigger separation. In addition, mitotic spindle dynamics and anaphase B contribute to the mechanical separation of chromatids. Understanding how these regulators coordinate ensures genomic stability, and their dysfunction is linked to tumorigenesis and chemoresistance. This article synthesizes authoritative GO annotations and verified literature to provide a research-grade overview of GO:0010965, its genes, mechanisms, and experimental models.
regulation of mitotic sister chromatid separation At A Glance
| GO ID | GO:0010965 |
|---|---|
| GO term | regulation of mitotic sister chromatid separation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of sister chromatid detachment during mitosis |
| Key regulators | Spindle assembly checkpoint proteins, separase, securin, PLK1, anaphase-promoting complex/cyclosome (APC/C) |
| Cellular context | Mitotic spindle, kinetochores, cohesin complexes |
| Disease relevance | Aneuploidy, cancer, chemoradiotherapy resistance |
What Is GO:0010965?
GO:0010965, regulation of mitotic sister chromatid separation, is defined as any process that modulates the frequency, rate or extent of mitotic sister chromatid separation. Mitotic sister chromatid separation itself is the process in which sister chromatids are physically detached from each other during mitosis. This regulatory term encompasses checkpoint control, ubiquitin-mediated proteolysis, and spindle dynamics that ensure timely and accurate chromatid disjunction.
Why Is regulation of mitotic sister chromatid separation Important in Cell Biology?
Regulation of mitotic sister chromatid separation is fundamental for genomic stability. Errors in this process cause aneuploidy, which is a hallmark of many cancers and is associated with tumor progression and drug resistance. The spindle assembly checkpoint ensures that cells do not initiate anaphase until all chromosomes are correctly attached, preventing chromosome mis-segregation. Moreover, the ubiquitin-proteasome equilibrium controlling PLK1 and separase activity is critical for timely separation, and its disruption can lead to premature or delayed chromatid disjunction. Understanding these regulatory mechanisms provides insights into cancer biology and identifies potential therapeutic targets, such as SAC kinases and separase.
• Prevents aneuploidy by ensuring accurate chromosome segregation.
• Spindle assembly checkpoint delays anaphase until all kinetochores are properly attached.
• Separase and securin provide a proteolytic switch for cohesin cleavage.
• PLK1 ubiquitination/deubiquitination equilibrium regulates separation timing.
• Anaphase B contributes to mechanical chromatid separation and spindle elongation.
• Deregulation is linked to cancer and chemoradiotherapy resistance.
• Provides targets for anti-mitotic cancer therapies.
• Essential for development and tissue homeostasis.
• Model organisms (yeast, Drosophila) reveal conserved mechanisms.
• Experimental modulation via CRISPR enables functional studies.
What Happens During regulation of mitotic sister chromatid separation?
Spindle Assembly Checkpoint (SAC) Surveillance
In simple terms: The cell has a safety checkpoint that makes sure all chromosomes are properly attached before they are pulled apart.
The spindle assembly checkpoint (SAC) monitors kinetochore-microtubule attachments and prevents anaphase onset until all chromosomes are bi-oriented. SAC proteins, including Mad and Bub family kinases, localize to unattached kinetochores and generate a 'wait' signal that inhibits the anaphase-promoting complex/cyclosome (APC/C). This delay allows time for error correction and ensures that sister chromatids separate only when the spindle is ready.
Separase Activation and Cohesin Cleavage
In simple terms: A molecular scissors called separase cuts the glue that holds sister chromatids together.
Separase (Cut1/separin) is a protease that cleaves the cohesin complex, the ring-like structure that holds sister chromatids together. Separase is kept inactive by binding to securin (Cut2); upon APC/C-mediated ubiquitination, securin is degraded, releasing separase to cleave cohesin and trigger sister chromatid separation. This proteolytic cascade is highly conserved from yeast to humans.
Ubiquitin-Proteasome Control of PLK1
In simple terms: Adding or removing ubiquitin tags on PLK1 controls when chromatids separate.
The equilibrium between ubiquitination and deubiquitination of PLK1 regulates sister chromatid separation. PLK1 activity is required for multiple mitotic events, and its timely degradation by the proteasome is essential for anaphase progression. Disruption of this balance leads to premature or delayed separation, highlighting the importance of ubiquitin dynamics in GO:0010965.
Anaphase B and Spindle Elongation
In simple terms: After the glue is cut, the spindle elongates to pull the separated chromatids to opposite poles.
Anaphase B is the phase of mitosis during which the spindle elongates and pushes the poles apart, contributing to sister chromatid separation. This process is driven by motor proteins and microtubule sliding, and is regulated by factors that control spindle dynamics. Proper anaphase B ensures that chromatids are fully separated and segregated into daughter cells.
Key Genes Involved in GO:0010965 regulation of mitotic sister chromatid separation
The following genes and proteins are central to the regulation of mitotic sister chromatid separation (GO:0010965), based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESPL1 (Separase) | Cleaves cohesin to trigger sister chromatid separation | Target for aneuploidy and cancer studies |
| PTTG1 (Securin) | Inhibits separase until degraded by APC/C | Regulates timing of separation; cancer biomarker |
| PLK1 | Kinase regulating mitotic progression; ubiquitination controls separation | Therapeutic target in oncology |
| BUB1 | SAC kinase; monitors kinetochore attachment | Mutated in cancers; checkpoint studies |
| BUBR1 (BUB1B) | SAC kinase; inhibits APC/C | Mosaic variegated aneuploidy syndrome |
| MAD1L1 | SAC component; sequesters CDC20 | Aneuploidy research |
| MAD2L1 | SAC component; inhibits APC/C | Cancer and checkpoint studies |
| CDC20 | Activates APC/C to degrade securin | Regulates anaphase onset |
| APC/C (complex) | Ubiquitin ligase targeting securin and PLK1 | Central to separation timing |
| CDK1 | Mitotic kinase; phosphorylates separase and regulates SAC | Cell cycle control |
| Aurora B | Chromosomal passenger kinase; error correction | Target in mitosis research |
| MPS1 (TTK) | SAC kinase; recruits SAC proteins | Checkpoint signaling |
| CENP-E | Kinetochore motor; SAC activation | Chromosome alignment |
| DYNEIN | Motor protein; spindle assembly and anaphase B | Spindle dynamics |
| KIF11 (Eg5) | Kinesin; spindle bipolarity | Mitotic motor studies |
| CLASP | Microtubule plus-end tracking protein; anaphase B | Spindle elongation |
| SEPARASE cofactors | Regulate separase activity and localization | Proteolysis research |
How Is regulation of mitotic sister chromatid separation Regulated?
Regulation of mitotic sister chromatid separation is controlled by the spindle assembly checkpoint, which inhibits APC/C until all chromosomes are properly attached. The APC/C, activated by CDC20, ubiquitinates securin and PLK1, leading to their degradation and allowing separase to cleave cohesin. Phosphorylation by CDK1 and PLK1 further modulates separase and SAC components. Additionally, deubiquitinases counteract ubiquitination to maintain the equilibrium of PLK1, ensuring timely separation. Anaphase B is regulated by motor proteins and microtubule-associated proteins that control spindle elongation.
regulation of mitotic sister chromatid separation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESPL1 | Aneuploidy, cancer | Knockout cell lines, xenografts |
| PTTG1 | Cancer, pituitary tumors | Overexpression and knockout models |
| PLK1 | Multiple cancers | Point mutation (kinase-dead), inhibitor studies |
| BUB1B | Mosaic variegated aneuploidy syndrome | Knock-in of patient mutations |
| MAD2L1 | Cancer, checkpoint defects | Knockout and knockdown models |
Cancer and Aneuploidy
Deregulation of sister chromatid separation leads to aneuploidy, a common feature of solid tumors and leukemias. Overexpression of separase or securin, or mutations in SAC genes such as BUB1B, are associated with tumorigenesis and poor prognosis. PLK1 is frequently overexpressed in cancers and is a target for small-molecule inhibitors.
Chemoradiotherapy Resistance
AMPK signaling, which intersects with mitotic regulation, has been implicated in chemoradiotherapy-induced oral mucositis, suggesting that metabolic and mitotic pathways may influence treatment response. Targeting SAC components could sensitize tumors to DNA-damaging agents.
Developmental Disorders
Mutations in SAC genes such as BUB1B cause mosaic variegated aneuploidy syndrome, characterized by growth retardation and cancer predisposition. This highlights the importance of accurate sister chromatid separation during development.
From regulation of mitotic sister chromatid separation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of separase cause aneuploidy? | ESPL1 knockout cell line |
| How does PLK1 ubiquitination affect separation? | PLK1 point mutant (ubiquitination-deficient) knock-in |
| What is the role of SAC kinase BUB1 in checkpoint? | BUB1 knockout and point mutation models |
| Can securin overexpression drive tumorigenesis? | PTTG1 overexpression transgenic model |
| How does anaphase B motor protein contribute? | KIF11 knockout or tagged knock-in |
| Does a SAC gene mutation cause developmental defects? | BUB1B knock-in mouse model |
How to Study the regulation of mitotic sister chromatid separation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Chromosome separation timing and dynamics | SAC and anaphase studies |
| Proteomics | Ubiquitination and protein interactions | PLK1 regulation |
| CRISPR knockout screens | Gene essentiality for separation | Discovery of novel regulators |
| Separase activity assay | Cohesin cleavage | Enzyme kinetics |
| Western blot | Securin degradation and PLK1 levels | Protein stability |
| Immunofluorescence | Kinetochore attachment and SAC proteins | Checkpoint activation |
| RNA-seq | Transcriptional changes upon gene perturbation | Pathway analysis |
| Flow cytometry | Cell cycle profile and aneuploidy | Phenotypic characterization |
Live-Cell Imaging of Chromosome Dynamics
Time-lapse microscopy of cells expressing fluorescently tagged histones and kinetochore proteins allows real-time visualization of sister chromatid separation and SAC satisfaction. This method quantifies the timing and fidelity of anaphase onset.
Proteomics and Ubiquitinome Analysis
Mass spectrometry-based proteomics can identify ubiquitination sites on PLK1 and other mitotic regulators, revealing the equilibrium between ubiquitination and deubiquitination. This approach helps map the signaling network controlling separation.
CRISPR-Based Functional Genomics
Genome-wide CRISPR knockout screens can identify genes required for sister chromatid separation and SAC function. Validated hits can be studied individually using knockout or point-mutation cell lines.
Biochemical Assays for Separase Activity
In vitro cleavage assays using recombinant separase and cohesin substrates measure proteolytic activity and the inhibitory effect of securin. These assays are complemented by western blotting for securin degradation.
How CRISPR Can Be Used to Study GO:0010965 regulation of mitotic sister chromatid separation
Knockout
CRISPR knockout of ESPL1, PTTG1, or SAC genes (e.g., BUB1, MAD2L1) in cell lines abolishes or impairs sister chromatid separation, leading to aneuploidy and cell cycle arrest. These models are used to study the consequences of losing specific regulators.
Point Mutation
Point mutations in PLK1 (e.g., kinase-dead or ubiquitination-deficient) can be introduced to dissect its role in separation without completely abolishing protein function. Such models reveal phosphorylation-dependent mechanisms.
Knock-in
Knock-in of patient-derived mutations in BUB1B or other SAC genes recapitulates disease-associated phenotypes, such as mosaic variegated aneuploidy. Tagged knock-in of separase or securin allows live-cell imaging of protein dynamics.
Overexpression
Overexpression of PTTG1 (securin) or PLK1 via CRISPR activation or lentiviral delivery models tumorigenic effects and chemoresistance. These models help identify therapeutic vulnerabilities.
How EDITGENE Supports regulation of mitotic sister chromatid separation Research
Researchers studying regulation of mitotic sister chromatid separation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in GO:0010965.
Contact EDITGENE today to design your custom CRISPR model for regulation of mitotic sister chromatid separation research.
Frequently Asked Questions About regulation of mitotic sister chromatid separation
What is GO:0010965?
GO:0010965 is the Gene Ontology term for regulation of mitotic sister chromatid separation, defined as any process that modulates the frequency, rate or extent of the physical detachment of sister chromatids during mitosis.
What genes are involved in regulation of mitotic sister chromatid separation?
Key genes include ESPL1 (separase), PTTG1 (securin), PLK1, BUB1, BUBR1, MAD1L1, MAD2L1, and CDC20.
How does the spindle assembly checkpoint regulate sister chromatid separation?
The SAC monitors kinetochore-microtubule attachments and inhibits APC/C until all chromosomes are properly attached, delaying anaphase.
What is the role of separase in sister chromatid separation?
Separase is a protease that cleaves cohesin, the ring that holds sister chromatids together, triggering their separation.
How is securin involved in sister chromatid separation?
Securin binds and inhibits separase until it is ubiquitinated and degraded by the proteasome, releasing active separase.
What diseases are linked to defects in sister chromatid separation?
Defects cause aneuploidy, cancer, and developmental disorders such as mosaic variegated aneuploidy syndrome.
How can CRISPR be used to study sister chromatid separation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes in this pathway.
What methods are used to study mitotic sister chromatid separation?
Live-cell imaging, proteomics, CRISPR screens, separase activity assays, and immunofluorescence are commonly used.
What is anaphase B and how does it relate to sister chromatid separation?
Anaphase B is the phase of spindle elongation that helps separate chromatids after cohesin cleavage.
How does PLK1 regulate sister chromatid separation?
PLK1 activity and its ubiquitination/deubiquitination equilibrium control mitotic progression and separation timing.
Conclusion
Regulation of mitotic sister chromatid separation (GO:0010965) is a tightly controlled process essential for genomic stability. The spindle assembly checkpoint, separase-securin proteolytic switch, PLK1 ubiquitination equilibrium, and anaphase B machinery coordinate to ensure accurate chromatid disjunction. Dysregulation leads to aneuploidy and cancer, making these components attractive for research and therapeutic targeting. CRISPR-based models and advanced imaging and proteomic methods continue to unravel the molecular details of this critical pathway.
References
- 1. Lischetti T et al.. 2015. Regulation of mitotic progression by the spindle assembly checkpoint.. Mol Cell Oncol 2(1):e970484 PMID: 27308407
- 2. Yanagida M. 2000. Cell cycle mechanisms of sister chromatid separation; roles of Cut1/separin and Cut2/securin.. Genes Cells 5(1):1-8 PMID: 10651900
- 3. Liu J et al.. 2017. The equilibrium of ubiquitination and deubiquitination at PLK1 regulates sister chromatid separation.. Cell Mol Life Sci 74(12):2127-2134 PMID: 28188342
- 4. Yanagida M. 1995. Frontier questions about sister chromatid separation in anaphase.. Bioessays 17(6):519-26 PMID: 7575493
- 5. Amon A. 1999. The spindle checkpoint.. Curr Opin Genet Dev 9(1):69-75 PMID: 10072359
- 6. Vukušić K et al.. 2021. Anaphase B: Long-standing models meet new concepts.. Semin Cell Dev Biol 117:127-139 PMID: 33849764
- 7. Jiang J et al.. 2025. AMPK in Chemoradiotherapy-Induced Oral Mucositis.. J Oral Pathol Med 54(5):325-333 PMID: 40091685
- 8. Fraschini R. 2017. Factors that Control Mitotic Spindle Dynamics.. Adv Exp Med Biol 925:89-101 PMID: 27722958
